Synapse - Jamie Chaft

Search Within

Jamie Erin Chaft

Results (289)

Perioperative pembrolizumab for early-stage non-small-cell lung cancer

Journal Article

Wakelee, H.; Liberman, M.; Kato, T.; Tsuboi, M.; Lee, S. H.; Gao, S.; Chen, K. N.; Dooms, C.; Majem, M.; Eigendorff, E.; more...
New England Journal of Medicine (2023)

Fulltext@MSK | Save

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

Journal Article

Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
Journal for ImmunoTherapy of Cancer (2023)

Fulltext@MSK | Save

Brief report: Safety and antitumor activity of durvalumab plus tremelimumab in programmed cell death-(ligand)1–monotherapy pretreated, advanced NSCLC: Results from a phase 1b clinical trial

Journal Article

Garon, E. B.; Spira, A. I.; Goldberg, S. B.; Chaft, J. E.; Papadimitrakopoulou, V.; Cascone, T.; Antonia, S. J.; Brahmer, J. R.; Camidge, D. R.; Powderly, J. D.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis

Journal Article

Rimner, A.; Moore, Z. R.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Abdulnour, R. E. E.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Cuaron, J.; more...
International Journal of Radiation Oncology, Biology, Physics (2023)

Fulltext@MSK | Save

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC

Journal Article

Alessi, J. V.; Ricciuti, B.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; Elkrief, A.; Rodig, S. J.; Lebow, E. S.; Eicholz, J. E.; more...
Nature Communications (2023)

Fulltext@MSK | Save

Updated survival, efficacy and safety of adjuvant (adj) atezolizumab (atezo) after neoadjuvant (neoadj) atezo in the phase II LCMC3 study

Meeting Abstract

Carbone, D. P.; Waqar, S. N.; Chaft, J.; Kris, M. G.; Johnson, B. E.; Lee, J. M.; Wistuba, I. I.; Kwiatkowski, D.; Bunn, P. A.; Schulze, K.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer

Conference Paper

Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
Mosby Elsevier (2023)

Fulltext@MSK | Save

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

Journal Article

Pai, J. A.; Hellmann, M. D.; Sauter, J. L.; Mattar, M.; Rizvi, H.; Woo, H. J.; Shah, N.; Nguyen, E. M.; Uddin, F. Z.; Quintanal-Villalonga, A.; more...
Cancer Cell (2023)

Fulltext@MSK | Save

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer

Journal Article

Rusch, V. W.; Nicholas, A.; Patterson, G. A.; Waqar, S. N.; Toloza, E. M.; Haura, E. B.; Raz, D. J.; Reckamp, K. L.; Merritt, R. E.; Owen, D. H.; more...
Journal of Thoracic and Cardiovascular Surgery (2023)

Fulltext@MSK | Save

Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review

Review

Blakely, C. M.; Weder, W.; Bubendorf, L.; He, J.; Majem, M.; Shyr, Y.; Chaft, J. E.
Lung Cancer (2023)

Fulltext@MSK | Save